Asian Spectator

Times Advertising

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

  • Written by ACN Newswire - Press Releases

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

SHANGHAI, CHINA, Jul 20, 2020 - (ACN Newswire) - Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and best-in-class therapies, today announced that it has successfully closed US$97 million in Series C financing.

The...

More Articles ...

  1. Top 7 Benefits That a CBD-Rich Oil Can Potentially Offer
  2. Australians concerned about their financial wellbeing as a result of COVID-19
  3. Fivetran Raises $100 Million to Accelerate Growth as Automated Data Integration Leader
  4. Commodities Intelligence Centre (CIC) introduces international Trade Data and Business Services, partners SBF to drive digital transformation of Singapore SMEs

Magazine

Bukan ‘malas’, penampilan Justin Bieber di Coachella menunjukkan cara kita menikmati musik daring

Kevin Mazur/Getty Images for CoachellaSetelah empat tahun absen dari tur, Justin Bieber tampil sebagai penampil utama di panggung Coachella. Namun, aksinya memicu kontroversi saat ia bernyanyi diiring...

Sederhana tapi menjebak: Bahaya tersembunyi konsep ‘love language’ dalam hubungan

Tahukah kamu bagaimana caramu memberi dan menerima kasih sayang? Apakah kamu tipe orang yang lebih menyukai words of affirmation (ungkapan sayang lewat kata-kata) atau quality time (menghabiskan waktu...

Legal Risks Every Business Owner Should Know

Running a business in Australia comes with a degree of legal exposure that many owners underestimate until a problem is already at their door. From contractual disputes to employment matters, the le...